By Justin Petrone

Seeking to capitalize on its experience with biomarker research and genomic technologies, Almac Diagnostics this week launched Biomarkers for Biopharma, a menu of services specifically designed to appeal to drug developers working in the preclinical setting.

Almac Diagnostics, which is part of the Craigavon, Northern Ireland-based drug development services firm the Almac Group, has offered its experience, particularly with array technology, to pharmaceutical partners before.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.